A Potential Role for CPY17 as a Parameter in Differentiation Between Aldosterone-producing Adenoma and Nodular Hyperplasia in Patients With Hyperaldosteronism

These results indicate that CPY17 was down-regulated in APA compared with that in NH, suggesting a potential role for CPY17 as a marker in differentiation between APA and NH in patients with hyperaldosteronism. Such a study might be helpful to improve the diagnosis and treatment of primary aldosteronism.